ME01157B - DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU - Google Patents

DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU

Info

Publication number
ME01157B
ME01157B MEP-2010-103A MEP10310A ME01157B ME 01157 B ME01157 B ME 01157B ME P10310 A MEP10310 A ME P10310A ME 01157 B ME01157 B ME 01157B
Authority
ME
Montenegro
Prior art keywords
group
pyrroine
carboxamides
imidazo
heterocyclic
Prior art date
Application number
MEP-2010-103A
Other languages
English (en)
Inventor
Jean-François Peyronel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ME01157B publication Critical patent/ME01157B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22Tin compounds
    • C07F7/2208Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Pronalazak se odnosi na jedinjenja formule (I) u kojoj : X je opcionalno supstituisana fenil grupa; R 1  je atom vodonika, halogena, (C 1 -C 6 )alkoksi grupa, (C 1 -C 6 )alkil grupa, NR a R b , grupa; R 2  je opcionalno supstituisana heterociklična grupa; R 3  je atom vodonika, (C 1 -C 6 )alkil grupa, (C 1 -C 6 )alkoksi grupa ili halogen atom; R 4  je atom vodonika, (C 1 -C 4 )alkil grupa, (C 1 -C 4 )alkoksi grupa ili atom fluora; navedena jedinjenja su u obliku baze ili soli adicione soli kiseline. Ova jedinjenja se mogu koristiti u terapeutske svrhe.  
MEP-2010-103A 2008-01-02 2008-12-31 DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU ME01157B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0800005A FR2925903B1 (fr) 2008-01-02 2008-01-02 DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
PCT/FR2008/001836 WO2009106750A2 (fr) 2008-01-02 2008-12-31 Dérivés 6-heterocyclique-imidazo[1,2-a]pyrroine-2-carboxamides, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
ME01157B true ME01157B (me) 2013-03-20

Family

ID=39745373

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-103A ME01157B (me) 2008-01-02 2008-12-31 DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU

Country Status (25)

Country Link
US (2) US8314109B2 (me)
EP (1) EP2225240B1 (me)
JP (1) JP5258899B2 (me)
KR (1) KR101600635B1 (me)
CN (1) CN101959884B (me)
AR (1) AR070074A1 (me)
AU (1) AU2008351928B2 (me)
BR (1) BRPI0821458A2 (me)
CA (1) CA2710947C (me)
CL (1) CL2008003928A1 (me)
CO (1) CO6331309A2 (me)
EA (1) EA019122B1 (me)
FR (1) FR2925903B1 (me)
HK (1) HK1148016A1 (me)
IL (1) IL206669A (me)
MA (1) MA32527B1 (me)
ME (1) ME01157B (me)
MX (1) MX2010007353A (me)
MY (1) MY155468A (me)
NZ (1) NZ586474A (me)
SG (1) SG187408A1 (me)
TW (1) TWI432432B (me)
UY (1) UY31589A1 (me)
WO (1) WO2009106750A2 (me)
ZA (1) ZA201004644B (me)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925907B1 (fr) * 2008-01-02 2010-10-15 Sanofi Aventis DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
EP2768832A1 (en) * 2011-10-21 2014-08-27 Torrent Pharmaceuticals Limited Novel substituted imidazopyrimidines as gpbar1 receptor modulators
KR101716993B1 (ko) 2012-12-25 2017-03-15 닛뽕소다 가부시키가이샤 할로겐화 아닐린 및 그 제조 방법
CN108295074B (zh) * 2018-02-01 2020-08-28 华中农业大学 一种噻二唑并三嗪类化合物在制备单胺氧化酶抑制剂中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638161B1 (fr) * 1988-10-24 1991-01-11 Centre Nat Rech Scient Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
IE904346A1 (en) * 1989-12-04 1991-06-05 Searle & Co IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF¹NEUROTOXIC INJURY
JP2006509497A (ja) * 2002-09-24 2006-03-23 ニューロ セラピューティクス エービー 神経発生に関する方法および物質
WO2004050659A1 (en) * 2002-11-27 2004-06-17 Eli Lilly And Company Novel compounds as pharmaceutical agents
WO2004103991A1 (fr) * 2003-05-20 2004-12-02 'chemical Diversity Research Institute', Ltd. Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
FR2903108B1 (fr) * 2006-07-03 2008-08-29 Sanofi Aventis Sa Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
FR2903107B1 (fr) 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2903106B1 (fr) * 2006-07-03 2010-07-30 Sanofi Aventis Utilisations de 2-benzoyl-imidazopyridines en therapeutique

Also Published As

Publication number Publication date
TW200934780A (en) 2009-08-16
KR20100109940A (ko) 2010-10-11
NZ586474A (en) 2012-06-29
SG187408A1 (en) 2013-02-28
UY31589A1 (es) 2009-08-03
US8691990B2 (en) 2014-04-08
IL206669A (en) 2015-07-30
JP5258899B2 (ja) 2013-08-07
ZA201004644B (en) 2011-11-30
AU2008351928A1 (en) 2009-09-03
EP2225240B1 (fr) 2014-01-22
EP2225240A2 (fr) 2010-09-08
EA201070814A1 (ru) 2011-02-28
EA019122B1 (ru) 2014-01-30
FR2925903A1 (fr) 2009-07-03
MY155468A (en) 2015-10-15
BRPI0821458A2 (pt) 2015-06-16
TWI432432B (zh) 2014-04-01
JP2011508760A (ja) 2011-03-17
AU2008351928B2 (en) 2013-11-21
WO2009106750A3 (fr) 2010-02-25
HK1148016A1 (me) 2011-08-26
MX2010007353A (es) 2010-08-18
AR070074A1 (es) 2010-03-10
FR2925903B1 (fr) 2011-01-21
US20130041152A1 (en) 2013-02-14
WO2009106750A2 (fr) 2009-09-03
IL206669A0 (en) 2010-12-30
CN101959884B (zh) 2013-02-27
US20100317675A1 (en) 2010-12-16
CN101959884A (zh) 2011-01-26
MA32527B1 (fr) 2011-08-01
US8314109B2 (en) 2012-11-20
CO6331309A2 (es) 2011-10-20
CL2008003928A1 (es) 2010-02-12
KR101600635B1 (ko) 2016-03-07
CA2710947A1 (fr) 2009-09-03
CA2710947C (fr) 2016-04-12

Similar Documents

Publication Publication Date Title
ME00615B (me) DERIVATI 2-ARIL-6-FENIL-IMIDAZO[1,2-α]PIRIDINA, NJIHOVO DOBIJANJE I NJIHOVA TERAPEUTSKA PRIMjENA
RS53348B (en) PROCEDURE FOR THE PREPARATION OF 3-SUBSTITUTED 2-AMINO-5-HALOBENZAMIDES
CY1117324T1 (el) Παραγωγα 1-φαινυλ-2-πυριδινυλ αλκυλ αλκοολων ως αναστολεις φωσφοδιεστερασης
RS52872B (en) PIRAL UNITS
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
RS53627B1 (en) N- (3-Amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
EA200801996A1 (ru) 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов
RS53142B (en) UNITS THAT HAVE ANTAGONISTIC ACTIVITY ON CRTH2
RS54506B1 (en) PICOLINAMIDE DERIVATIVES AS KINASE INHIBITORS
WO2008030744A3 (en) Inhibitors of c-met and uses thereof
EA200970207A1 (ru) Соединения пиридо[2,3-d]пиримидинона и их применение в качестве pi3 ингибиторов
EA200601620A1 (ru) 5,6-диалкил-7-аминотриазолопиримидины, способ их получения и их применение для борьбы с патогенными растениями, а также содержащие их средства
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
RS54183B1 (en) PIRAZOLE DERIVATIVES
WO2010089510A3 (fr) Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
EA201170099A1 (ru) Замещенные пиримидин-4-оновые производные
WO2010010288A3 (fr) Derives de carbamates d' alkylthiazoles, leur preparation et leur utilisation comme inhbiteurs de l'enzyme faah
CO6460742A2 (es) Derivados de ciclopenta[c]pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su aplicación en terapéutica
RS54595B1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
ME00957B (me) Derivati alkinil7-alkinil-1,8-naftirodoni, njihova priprema i primjena u liječenju
MX2016003422A (es) Imidazo[1,2-a]piridina-7-aminas como herramientas de imagen.
ME01157B (me) DERlVATI 6-HETEROCIKLIČNOG-IMIDAZO[1,2-a]PIRIDIN-2 -KARBOKSAMIDA, NJIHOVA PRIPREMA I NJIHOVA PRIMJENA U LIJEČENJU
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
EA201000604A1 (ru) Новые производные имидазола
ATE389634T1 (de) Den vanilliod-trpv1-rezeptor antagonisierende sulfonamidoverbindungen